Galanthamine | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Galanthamine
Canada

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Galanthamine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 15 USDMF, 8 CEP/COS, 4 JDMF, 2 EU WC, 5 KDMF, 7 NDC API, 15 Listed Suppliers, $ API Reference Price

29 API Suppliers
15 USDMF
8 CEP/COS
4 JDMF
2 EU WC
5 KDMF
7 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

246 FDF Dossiers, 71 FDA Orange Book, 110 Europe, 15 Canada, 24 Australia, 9 South Africa, 17 Listed Dossiers

246 FDF Dossiers
71 FDA Orange Book
110 Europe
15 Canada
24 Australia
9 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - EQ 16MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - EQ 16MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 9 DKSH, 2 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 48 Direct Compression, 35 Disintegrants & Superdisintegrants, 33 Thickeners and Stabilizers, 33 Controlled & Modified Release, 30 Granulation, 26 Solubilizers, 23 Taste Masking, 22 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 18 Film Formers & Plasticizers, 17 Parenteral, 15 Topical, 9 Empty Capsules, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Coloring Agents, 5 Surfactant & Foaming Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules

92 Fillers, Diluents & Binders
53 Coating Systems & Additives
48 Direct Compression
35 Disintegrants & Superdisintegrants
33 Thickeners and Stabilizers
33 Controlled & Modified Release
30 Granulation
26 Solubilizers
23 Taste Masking
22 Lubricants & Glidants
19 Chewable & Orodispersible Aids
19 Co-Processed Excipients
18 Film Formers & Plasticizers
17 Parenteral
15 Topical
9 Empty Capsules
8 Emulsifying Agents
6 API Stability Enhancers
5 Coloring Agents
5 Surfactant & Foaming Agents
4 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 8 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 96 Finished Drug Prices, 6 Annual Reports

3 US Medicaid Prescriptions
96 Finished Drug Prices
6 Annual Reports

MARKET PLACE

5 APIs

5 APIs

PATENTS & EXCLUSIVITIES

20 Health Canada Patents

20 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 3 Others

4 EDQM
3 USP
3 Others

$ API Ref.Price (USD/KG) : 5,234 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

15 All

01 3AURO PHARMA INC

02 3JANSSEN INC

03 3MYLAN PHARMACEUTICALS ULC

04 3Pharmascience Inc.

05 3SANIS HEALTH INC

filter Active Ingredients Reset all filters

15 All

01 12GALANTAMINE (GALANTAMINE HYDROBROMIDE)

02 3Galantamine Hydrobromide

filter Dosage Form Reset all filters

15 All

01 15CAPSULE (EXTENDED RELEASE)

filter Brand Name Reset all filters

15 All

01 3AURO-GALANTAMINE ER

02 3GALANTAMINE ER

03 3MYLAN-GALANTAMINE ER

04 3PAT-GALANTAMINE ER

05 3PMS-GALANTAMINE ER

Capital Farma Galantamine Hydrobromide

List of Suppliers

Product Main Page

01

AURO PHARMA INC

2024 ACI Convention

Not Confirmed

AURO PHARMA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Brand Name : AURO-GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 8MG

Packaging : 30/100/500/1000

Approval Date :

Application Number : 2425157

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Galantamine Hydrobromide

Brand Name : PMS-GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 24MG

Packaging : 30/100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

03

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Galantamine Hydrobromide

Brand Name : PMS-GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 8MG

Packaging : 30/100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

04

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Galantamine Hydrobromide

Brand Name : PMS-GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 16MG

Packaging : 30/100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Brand Name : GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 8MG

Packaging : 100

Approval Date :

Application Number : 2443015

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Brand Name : GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 16MG

Packaging : 100

Approval Date :

Application Number : 2443023

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Brand Name : GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 24MG

Packaging : 100

Approval Date :

Application Number : 2443031

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MYLAN PHARMACEUTICALS ULC

2024 ACI Convention

Not Confirmed

MYLAN PHARMACEUTICALS ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Brand Name : MYLAN-GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 8MG

Packaging : 30/100

Approval Date :

Application Number : 2339439

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MYLAN PHARMACEUTICALS ULC

2024 ACI Convention

Not Confirmed

MYLAN PHARMACEUTICALS ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Brand Name : MYLAN-GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 16MG

Packaging : 30/100

Approval Date :

Application Number : 2339447

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MYLAN PHARMACEUTICALS ULC

2024 ACI Convention

Not Confirmed

MYLAN PHARMACEUTICALS ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Brand Name : MYLAN-GALANTAMINE ER

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 24MG

Packaging : 30/100

Approval Date :

Application Number : 2339455

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?